Showing results (1731-1740 of 2,129) with videos related to
Sort By:
Pageof 213
Clinical Genetics|August 11, 2025
The Role of Whole-Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo-Humeral Muscular Dystrophy CasesFrancesca Torri, Claudia Strafella, Liliana Vercelli, et al.Oncotarget|December 10, 2017
KIF3A and IL-4 are disease-specific biomarkers for psoriatic arthritis susceptibilityRaffaella Cascella, Claudia Strafella, Michele Ragazzo, et al.Circulation. Cardiovascular Quality and Outcomes|November 15, 2022
Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation StrategyKatja Reuter, Kirali Genao, Emily M Callanan, et al.Human Vaccines & Immunotherapeutics|August 7, 2023
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of ageKai Chu, Yuemei Hu, Hongxing Pan, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2019
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 ProductionGermana Lentini, Agata Famà, Carmelo Biondo, et al.Clinical and Experimental Rheumatology|August 2, 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational studyRossana Scrivo, Chiara Castellani, Silvia Mancuso, et al.Blood|November 1, 1988
Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alphaS L Giardina, H A Young, C R Faltynek, et al.Microorganisms|September 23, 2022
Retrospective Analysis of Leishmaniasis in Sicily (Italy) from 2013 to 2021: One-Health Impact and Future Control StrategiesFederica Bruno, Fabrizio Vitale, Francesco La Russa, et al.Vaccine|September 26, 2021
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccinesYoshitaka Yamazaki, Masanori Ikeda, Takayuki Imada, et al.Iscience|February 2, 2026
Structure and function of persulfide dioxygenase from Pseudomonas aeruginosa: Implications on H2S homeostasis and interplay with nitric oxideFrancesca Giordano, Francesca Troilo, Martina Roberta Nastasi, et al.Pageof 213